Aclidinium improves exercise endurance, dyspnea, lung hyperinflation, and physical activity in patients with COPD: a randomized, placebo-controlled, crossover trial.

Aclidinium improves exercise endurance, dyspnea, lung hyperinflation, and physical activity in patients with COPD: a randomized, placebo-controlled, crossover trial.

Item
http://www.wikidata.org/entity/Q35191130
COPD: the patient perspectiveStudy Design of VESUTO®: Efficacy of Tiotropium/Olodaterol on Lung Hyperinflation, Exercise Capacity, and Physical Activity in Japanese Patients with Chronic Obstructive Pulmonary Disease.Effects of pharmacologic treatment based on airflow limitation and breathlessness on daily physical activity in patients with chronic obstructive pulmonary disease.Effects of indacaterol/glycopyrronium (QVA149) on lung hyperinflation and physical activity in patients with moderate to severe COPD: a randomised, placebo-controlled, crossover study (The MOVE Study).Enhancing exercise tolerance and physical activity in COPD with combined pharmacological and non-pharmacological interventions: PHYSACTO randomised, placebo-controlled study design.Differences in physical activity according to mMRC grade in patients with COPDEffect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials.Long-acting muscarinic antagonists.Aclidinium bromide inhalation powder for the long-term, maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease including chronic bronchitis and emphysema.ACTIVATE: the effect of aclidinium/formoterol on hyperinflation, exercise capacity, and physical activity in patients with COPDLong-acting bronchodilators improve exercise capacity in COPD patients: a systematic review and meta-analysis.The Link between Reduced Inspiratory Capacity and Exercise Intolerance in Chronic Obstructive Pulmonary Disease.Effect of 12 weeks of once-daily tiotropium/olodaterol on exercise endurance during constant work-rate cycling and endurance shuttle walking in chronic obstructive pulmonary disease.Chronic Obstructive Pulmonary Disease: When Pulmonologists Do Something Good for the Heart.8th International conference on management and rehabilitation of chronic respiratory failure: the long summaries – part 2.Verification of a Motion Sensor for Evaluating Physical Activity in COPD Patients.Dose-response of an extrafine dry powder inhaler formulation of glycopyrronium bromide: randomized, double-blind, placebo-controlled, dose-ranging study (GlycoNEXT).
P2860

Aclidinium improves exercise endurance, dyspnea, lung hyperinflation, and physical activity in patients with COPD: a randomized, placebo-controlled, crossover trial.

Item
http://www.wikidata.org/entity/Q35191130
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Aclidinium improves exercise e ...... o-controlled, crossover trial.
@ast
Aclidinium improves exercise e ...... o-controlled, crossover trial.
@en
type
label
Aclidinium improves exercise e ...... o-controlled, crossover trial.
@ast
Aclidinium improves exercise e ...... o-controlled, crossover trial.
@en
prefLabel
Aclidinium improves exercise e ...... o-controlled, crossover trial.
@ast
Aclidinium improves exercise e ...... o-controlled, crossover trial.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P478
P50
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
Aclidinium improves exercise e ...... o-controlled, crossover trial.
@en
P2093
P2860
P2888
P304
P31
P356
P478
P50
P577
P5875
P6179
P698
P921
P932